Poland· PL-100455180
Lydisilka
A drospirenone and estetrol product containing drospirenonum + estetrolum, registered in Poland by Estetra SRL. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Drospirenone and estetrol is registered in 12 of 19 countries.
Countries holding a registration under ATC G03AA18 (drospirenone and estetrol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Drospirenone and estetrol · ATC G03AA18
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Drospirenonum + Estetrolum
- Manufacturer
- Estetra SRL
- Country
- Poland (PL)
- ATC code
- G03AA18
- ATC class
- Drospirenone and estetrol
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Drospirenone and estetrol in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandDrovelis 3 mg/14.2 mg, FilmtablettenGedeon Richter (Schweiz) AG
- IcelandDrovelisGedeon Richter Plc.*
- NetherlandsDrovelis 14,2mg/3 mg, filmomhulde tablettenGedeon Richter Plc
- SpainDROVELIS 3 MG/14,2 MG COMPRIMIDOS RECUBIERTOS CON PELICULAGedeon Richter Plc.
- United KingdomDrovelis 3mg/14.2mg tabletsGedeon Richter (UK) Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/935cb683-01b1-4c7f-84e5-c2b78637e98c GET /v1/drugs/935cb683-01b1-4c7f-84e5-c2b78637e98c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "3 mg + 14,2 mg",
"packaging": "Rp ¦ EU/1/21/1548/004 ¦ 141051\n364 tabl.\nRp ¦ EU/1/21/1548/001 ¦ 141052\n28 tabl.\nRp ¦ EU/1/21/1548/003 ¦ 141053\n168 tabl.\nRp ¦ EU/1/21/1548/002 ¦ 141054\n84 tabl.",
"substance": "Drospirenonum 3 mg + Estetrolum 14.2 mg",
"common_name": "Drospirenonum + Estetrolum",
"pl_product_id": "100455180",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about drospirenone and estetrol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.